Topics

PROVE-HF Cracks the 'Holy Grail' of Cardiac Remodeling in HFrEF

08:00 EDT 7 Oct 2019 | Medscape

Ileana Piña, MD speaks with lead author Jim Januzzi, MD, about the path to PROVE-HF and how sacubitril/valsartan benefits real-world patients with heart failure with reduced ejection fraction.
theheart.org on Medscape

Original Article: PROVE-HF Cracks the 'Holy Grail' of Cardiac Remodeling in HFrEF

NEXT ARTICLE

More From BioPortfolio on "PROVE-HF Cracks the 'Holy Grail' of Cardiac Remodeling in HFrEF"

Quick Search